WILMINGTON — Hervé Hoppenot, president and CEO of Delaware’s pioneering biopharmaceutical company Incyte who has helped guide the company to new heights, has been named the 2024 Pete du Pont Freedom Award honoree.
This award is presented each year by the Pete du Pont Freedom Foundation to an individual or an organization that has championed a successful idea that has led to economic growth or brought innovation to the private sector. In the past, the award has been given to national names, but also includes Delawareans such as Vance Kershner, Carol Ammon, Mike Castle and leaders at the former MBNA.
Hoppenot joined Incyte a decade ago after leaving his job as the head of Swiss-American pharmaceutical giant Novartis’ oncology program. At the time, Incyte had big plans for the next decade for investment in research and development as well as team development. Under his leadership, Incyte has grown in leaps and bounds, tripling its …